Revisions to interim and full-year earnings forecasts. Interim net sales up +4.1% from previous forecast, operating income up +12.8%, ordinary income up +4.0%, net income attributable to owners of parent for the interim up +10.5%. Full-year net sales up +6.8%, operating income up +12.8%, ordinary income up +4.0%, net income up +4.1%. Dividend forecast unchanged.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4208","jir_company_name":"UBE Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4208-20261102-01.pdf","jir_short_summary":"Revisions to interim and full-year earnings forecasts. Interim net sales up +4.1% from previous forecast, operating income up +12.8%, ordinary income up +4.0%, net income attributable to owners of parent for the interim up +10.5%. Full-year net sales up +6.8%, operating income up +12.8%, ordinary income up +4.0%, net income up +4.1%. Dividend forecast unchanged.","jir_summary":"### Revision of Forecasts and Background\nThis document revises the interim and full-year earnings forecasts announced on May 13, 2026. Interim net sales are expected to exceed the previous forecast due to sales price increases driven by rising raw material and fuel costs in the Resins & Chemicals segment, and operating income, ordinary income and interim net income are also expected to increase. For the full consolidated fiscal year, solid sales are expected across multiple segments led by Resins & Chemicals, resulting in projections above the previous forecast. The dividend forecast remains unchanged.\n\n### Outlook and Segmental Impact\nThe full-year forecast for the fiscal year ending March 2027 raises net sales driven by price increases in the Resins & Chemicals segment; although integration costs in the Functional Products & Machinery segment will increase, the overall view is above the previous forecast. Weak sales in the Pharmaceuticals segment will have an impact, but overall profit levels are expected to improve. Specific figures depend on the latest revised forecasts.","jir_financial_highlights":"Net Sales: 244,700 million yen (vs. previous forecast (A) +9,700)\nOperating Income: 12,200 million yen (vs. previous forecast (A) +6,700)\nOrdinary Income: 20,500 million yen (vs. previous forecast (A) +6,500)\nNet Income Attributable to Owners of Parent (interim): 10,500 million yen (vs. previous forecast (A) +1,000)","jir_category":"","jir_hashtags":"#UBE, #EarningsForecastRevision","jir_key_figures":"Net Sales: 244,700 million yen (interim)\nOperating Income: 12,200 million yen (interim)\nNet Income Attributable to Owners of Parent: 10,500 million yen (interim)","jir_meta_title":"UBE Corporation Revises Earnings Forecasts\uff5cRaises Interim and Full-Year Sales and Profit Outlooks","jir_meta_description":"UBE Corporation announces revisions to its earnings forecasts. Summary of changes and background for interim and full-year net sales, operating income, ordinary income, and interim net income attributable to owners of parent. Dividend forecast unchanged.","jir_og_title":"UBE Corporation Announces Revision to Earnings Forecasts","jir_og_description":"UBE Corporation has revised its interim and full-year earnings forecasts. Sales and profit outlooks have been raised while dividends remain unchanged. See the document for detailed figures.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8772,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-140080","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n